Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014–2021

Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches

(2023) A. J. Lepak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections

(2021) Pranita D Tamma et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)

(2019) Ana C Gales et al.   Open Forum Infectious Diseases

In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: Results from the SENTRY Antimicrobial Surveillance Program (2014-2018)

(2019) Robert K. Flamm et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years

(2018) Consuelo Velázquez-Acosta et al.   SUPPORTIVE CARE IN CANCER

Minocycline susceptibility breakpoints for Acinetobacter baumannii: do we need to re-evaluate them?

(2018) Athanasios Tsakris et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial

(2017) J Nowak et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges

(2016) Darren Wong et al.   CLINICAL MICROBIOLOGY REVIEWS

Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia , and Burkholderia cepacia species complex isolates from a global surveillance program (2013)

(2016) Robert K. Flamm et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment ofStenotrophomonas maltophiliainfections

(2016) Elizabeth Hand et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Distribution of Class 1 Integrons,sul1andsul2Genes Among Clinical Isolates ofStenotrophomonas maltophiliafrom a Tertiary Care Hospital in North India

(2015) Parvinder Kaur et al.   Microbial Drug Resistance

Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options

(2015) Ya-Ting Chang et al.   Frontiers in Microbiology

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Considerations when prescribing trimethoprim-sulfamethoxazole

(2011) J. M.- W. Ho et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature

(2009) Matthew E Falagas et al.   Future Microbiology

Risk Factors for Mortality in Patients with Nosocomial Stenotrophomonas maltophilia Pneumonia

(2009) Chia-Cheng Tseng et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS